enVVeno Medical Corporation (NVNO) Financials

NVNO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 48.6 million 2.4 million
2023-09-30 28.1 million 3.2 million
2023-06-30 32.1 million 3.3 million
2023-03-31 36.6 million 2.5 million

NVNO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -5.0 million 1.1 million
2023-09-30 -4.2 million 1.1 million
2023-06-30 -4.6 million 1.2 million
2023-03-31 -5.1 million 1.8 million

NVNO Net Income

No data available :(

NVNO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 46.4 million - 1.4 million
2023-09-30 25.7 million - 1.5 million
2023-06-30 29.8 million - 1.6 million
2023-03-31 34.2 million - 1.6 million

NVNO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 13.3 million
2023-09-30 11.2 million
2023-06-30 11.2 million
2023-03-31 11.2 million

NVNO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4000 3.0 million 3.3 million -
2023-09-30 3000 2.8 million 2.6 million -
2023-06-30 21000 4.2 million 2.6 million -
2023-03-31 5000 3.6 million 3.2 million -

NVNO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 824000 134000
2023-09-30 - 138000
2023-06-30 - 138000
2023-03-31 - 136000

NVNO

Price: $5.27

52 week price:
2.51
6.97

Earnings Per Share: -1.91 USD

P/E Ratio: -1.96

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 50300

Market Capitalization: 68.3 million

Links: